Related Experiment Video
Updated: Jul 16, 2026

Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry
Published on: June 26, 2019
Adenoviral E1B55K oncoprotein sequesters candidate leukemia suppressor sequence-specific single-stranded DNA-binding
H B Fleisig1, N I Orazio, H Liang
1Department of Molecular Genetics, MD Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
Sequence-specific single-stranded DNA-binding protein 2 (SSBP2) is a candidate tumor suppressor for human acute myelogenous leukemia (AML). Inducible expression of SSBP2 causes growth arrest and partial differentiation in AML cells. Here, we report that the adenoviral oncoprotein E1B55K directly binds to endogenous SSBP2 protein and sequesters it into juxtanuclear bodies in adenovirally transformed human embryonic kidney (HEK) 293 cells. Similarly, transient expression of E1B55K in IMR90 fibroblasts and HeLa cells result in the formation of juxtanuclear bodies containing SSBP2. When nuclear export of E1B55K is prevented, SSBP2 remains associated with E1B55K in nuclear foci. A requirement for intact microtubules to retain the integrity of the juxtanuclear bodies suggests them to be E1B55K containing aggresomes. The adenoviral E1B55K protein has been shown to localize to the Mre11 complex and p53 to aggresome structures; together with the viral E4orf6 protein, E1B55K recruits a cellular E3 ubiquitin ligase that induces degradation of Mre11 and p53. However, our present studies reveal that E1B55K does not degrade SSBP2. These data demonstrate that E1B55K targets the candidate leukemia suppressor SSBP2 and suggest that subverting its function may contribute to cell transformation by viral oncoproteins.
Insights
Adenoviral oncoprotein E1B55K binds to sequence-specific single-stranded DNA-binding protein 2 (SSBP2), a potential acute myelogenous leukemia (AML) tumor suppressor. E1B55K sequesters SSBP2 into aggresomes, but does not degrade it.
Area of Science:
- Molecular Biology
- Oncology
- Virology
Background:
- Sequence-specific single-stranded DNA-binding protein 2 (SSBP2) acts as a tumor suppressor in acute myelogenous leukemia (AML).
- Adenoviral oncoprotein E1B55K is known to interact with cellular proteins and influence cell transformation.
Purpose of the Study:
- To investigate the interaction between adenoviral oncoprotein E1B55K and SSBP2.
- To determine the effect of E1B55K on SSBP2 localization and stability.
Main Methods:
- Co-immunoprecipitation assays to detect protein binding.
- Immunofluorescence microscopy to visualize protein localization.
- Cell culture experiments in HEK 293, IMR90, and HeLa cells.
Main Results:
- Adenoviral E1B55K directly binds to endogenous SSBP2.
- E1B55K sequesters SSBP2 into juxtanuclear bodies, identified as aggresomes, dependent on intact microtubules.
- SSBP2 remains associated with E1B55K in nuclear foci when nuclear export is inhibited.
- Unlike Mre11 and p53, SSBP2 is not degraded by E1B55K.
Conclusions:
- Adenoviral E1B55K targets the candidate leukemia suppressor SSBP2.
- Subversion of SSBP2 function by E1B55K may contribute to viral oncoprotein-mediated cell transformation.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation
Regulation of Nuclear Protein Sorting

